AZD-0837(433937-93-0)
- Name: AZD-0837
- Synonyms:Ph(3-Cl)(5-OCHF2)-(R)CH(OH)C(O)-Aze-Pab(MeO);Ph(3-Cl)(5-OCHF2)-(R)CH(OH)C(O)-Aze-Pab(OMe);
- Molecular Formula:C22H23ClF2N4O5
- Molecular Weight:496.898
- CAS Registry Number:433937-93-0
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.433937-93-0 AZD-0837
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.433937-93-0 AZD-0837
Assay:99% Application:Fine chemical intermediates, used as the main raw material for he synthesis of various pesticides, medicines, surfactants, polymer monomers, Ond Ontifungal agents
Min. Order:0
Supplier:Antimex Chemical Limied [
China (Mainland)] CAS No.433937-93-0 AZD-0837
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:AZD-0837
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)] CAS No.433937-93-0 AZD-0837
Assay:99% Appearance:liquid or powder Package:according to the clients requirement Storage:Dry and Cool Place Transportation:UPS FedEx ,DHL,EXPRESS LINE Application:API
Min. Order:1Gram
Supplier:Shandong Mopai Biotechnology Co., LTD [
China (Mainland)] CAS No.433937-93-0 AZD-0837
Assay:鈮?5% Appearance:Solid powder Package:inquiry Storage:Store at -20 掳C Transportation:inquiry Application:AZD0837 is an oral direct thrombin inhibitor currently in clinical development for the prevention of stroke and systemic embolic events in patients with atrial fibrillation.
Min. Order:0
Supplier:BOC Sciences [
United States]
Other Product
- 477793-57-0/Carbamic acid, N-[(1S)-2-[[(1S,2R)-1-[(3,5-difluorophenyl)methyl]-3-[[(3-ethylphenyl)methyl]amino]-2-hydroxypropyl]amino]-2-oxo-1-[[(1-propylbutyl)sulfonyl]methyl]ethyl]-, 3-pyridinylmethyl ester
- 477790-92-4/Carbamic acid, N-[(1S)-2-[[(1S,2R)-1-[(3,5-difluorophenyl)methyl]-3-[[(3-ethylphenyl)methyl]amino]-2-hydroxypropyl]amino]-2-oxo-1-[[(1-propylbutyl)sulfonyl]methyl]ethyl]-, 3-pyridinylmethyl ester, HCl Salt
- 978-62-1/IMD-0354
- 212631-67-9/PD 184161
- 954406-32-7/Acetamide, 2-[4-chloro-2-(3-chloro-5-cyanobenzoyl)phenoxy]-N-[3-fluoro-4-(2-hydroxy-2-methylpropoxy)-2-methylphenyl]-
- 1160597-06-7/CYT 387
- 867331-64-4/TG 100572 (Hydrochloride)
- 1018069-81-2/TG 100801 (Hydrochloride)
- 885482-95-1/SKS-927
- 473727-83-2/(R)-2-hydroxy-N,N-dimethyl-3-(2-(1-(5-methylfuran-2-yl)propylamino)-3,4-dioxocyclobut-1-enylamino)benzamide
- 159633-92-8/MK-677, HCl salt
- 1001350-96-4/BMS-754807
- 728033-96-3/OSI-930
- 692737-80-7/TKI 258
- 857402-63-2/Unii-928Q33Q049
- 871575-98-3/(2R)-[N-(Benzyloxycarbonyl)-D-phenylalanyl-L-prolylamino]-4-methoxybutylboronic acid sodium salt
- 667917-16-0/L-Prolinamide, N-[(phenylmethoxy)carbonyl]-D-phenylalanyl-N-[(1S)-1-borono-4-methoxybutyl]- (9CI)
- 942999-67-9/Bicyclo[2.2.2]octane-1-acetic acid, 4-[4-(4-amino-7,7-dimethyl-7H-pyrimido[4,5-b][1,4]oxazin-6-yl)phenyl]- ，AcOH salt
- 433937-74-7/2-Azetidinecarboxamide, N-[[4-(aminoiminomethyl)phenyl]methyl]-1-[(2R)-2-[3-chloro-5-(difluoromethoxy)phenyl]-2-hydroxyacetyl]-, (2S)-
- 433937-93-0/AZD-0837
- 945667-22-1/Saxagliptin hydrate
- 478644-12-1/GW 813893
- 218298-21-6/Razaxaban
- 201933-41-7/YM-60828
- 850649-61-5/ALOGLIPTIN(ALOGLIPTINE, ALOGLIPTINA)
- 852329-66-9/Dutogliptin
- 813452-18-5/(S)-1-((2S,3S,11bS)-2-amino-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1H-pyrido[2,1-a]isoquinolin-3-yl)-4-(fluoromethyl)pyrrolidin-2-one
- 887781-62-6/MK-0674
- 676559-83-4/ABT-279
- 956697-53-3/NVP-LDE225